CD14 and type 2 diabetes mellitus: Amongst CD14+ monocytes, we found that a 1.4‐fold decrease in classical monocyte (CD14Hi, CD16−) frequency specifically accounted for the decrease in total monocytes in T2D relative to ND COVID‐19 patients (Fig 1B).